Legal Opinion
Ferring Pharmaceuticals, Inc. v. Burwell
District Court, District of Columbia
Decided March 15, 2016No. Civil Action No. 2015-0802PublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION
Granting in Part and Denying in Part Defendants’ Motion for Summary Judgment and Denying Plaintiff’s Motion for Summary Judgment
RUDOLPH CONTRERAS, United States District Judge
I. INTRODUCTION
Plaintiff Ferring Pharmaceuticals, Inc. (“Ferring”) is the manufacturer of PRE-POPIK, a fixed-dose combination drug product that contains three drug substances: sodium picosulfate, magnesium oxide, and anhydrous citric acid. When it submitted a New Drug Application (“NDA”) for PREPOPIK to the U.S. Food and Drug Administration (“the FDA”), Ferring sought a five-year period of marketing…
2Cases cited38 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Burlington Truck Lines, Inc. v. United StatesSupreme Court of the United States · 1962
- National Cable & Telecommunications Assn. v. Brand X Internet ServicesSupreme Court of the United States · 2005
- Thomas Jefferson University v. ShalalaSupreme Court of the United States · 1994
33 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Otsuka Pharm. Co. v. BurwellCourt of Appeals for the D.C. Circuit · 2016
- Ferring Pharm., Inc. v. AzarCourt of Appeals for the D.C. Circuit · 2018
- Ferring Pharmaceuticals, Inc. v. BurwellDistrict Court, District of Columbia · 2016
- Ferring Pharmaceuticals, Inc. v. BurwellDistrict Court, District of Columbia · 2018
- Otsuka Pharmaceutical Co., Ltd. v. BurwellDistrict Court, District of Columbia · 2016